Literature DB >> 26351303

Feasibility of Electroporation in Bone and in the Surrounding Clinically Relevant Structures: A Preclinical Investigation.

Matilde Tschon1,2, Francesca Salamanna2, Mattia Ronchetti3, Francesco Cavani4, Alessandro Gasbarrini5, Stefano Boriani5, Milena Fini6,2.   

Abstract

Skeletal metastases are a common cause of severe morbidity, reduction in quality of life and often early mortality. Consequently, improvements in therapies are necessary. Electroporation uses electric energy to alter cancer cell membrane permeability and enhance the local uptake of chemotherapeutics, thus leading to local tumor control. The aim of this study was to investigate the feasibility and safety of delivering electric field protocols causing electroporation of healthy bone and structures of clinical relevance using small and large animal models. Reversible electroporation was used in the rabbit sciatic nerve by applying 2 series of 8 pulses 100ms long at 1000 V/cm. Irreversible electroporation was used in rabbit distal femur condyles and in sheep vertebral body by applying 120 pulses 100ms long at 1750 V/cm. Any effect on surrounding sensitive structures was investigated. Reversible electroporation of sciatic nerve was associated with transient foot functional deficit that completely recovered at 30 days. Irreversible electroporation removed cells from trabeculae in the femurs of rabbits and in the vertebral body of sheep. After irreversible protocol, histology and microtomography demonstrated that the trabecular structure was maintained, the presence of new bone marrow cells, osteoblasts, and mineral apposition characterized by new trabeculae thinner than controls (P = .005) and a significant reduction in the ablated areas (-225%, P = .0219). Spinal cord, vertebral pedicles and spinal nerves showed transient edema in the absence of functional or structural alterations. Collectively, these results show that electroporation can be safely applied to bone even in the proximity of neuronal structures.
© The Author(s) 2015.

Entities:  

Keywords:  bone tissue; electroporation; nerve; spinal cord; tumor ablation treatment

Mesh:

Year:  2015        PMID: 26351303     DOI: 10.1177/1533034615604454

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  5 in total

1.  Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective Analysis.

Authors:  Daniela Rega; Vincenza Granata; Antonella Petrillo; Ugo Pace; Massimiliano Di Marzo; Roberta Fusco; Valeria D'Alessio; Guglielmo Nasti; Carmela Romano; Antonio Avallone; Vincenzo Ravo; Fabiana Tatangelo; Piera Maiolino; Raffaele Palaia; Francesco Izzo; Paolo Delrio
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

Review 2.  Histological, Histomorphometrical, and Biomechanical Studies of Bone-Implanted Medical Devices: Hard Resin Embedding.

Authors:  M Maglio; F Salamanna; S Brogini; V Borsari; S Pagani; N Nicoli Aldini; G Giavaresi; M Fini
Journal:  Biomed Res Int       Date:  2020-01-17       Impact factor: 3.411

Review 3.  Non-viral Gene Delivery Methods for Bone and Joints.

Authors:  Benjamin Gantenbein; Shirley Tang; Julien Guerrero; Natalia Higuita-Castro; Ana I Salazar-Puerta; Andreas S Croft; Amiq Gazdhar; Devina Purmessur
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

Review 4.  A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response.

Authors:  Vincenza Granata; Roberta Fusco; Simona Salati; Antonella Petrillo; Elio Di Bernardo; Roberta Grassi; Raffaele Palaia; Ginevra Danti; Michelearcangelo La Porta; Matteo Cadossi; Gorana Gašljević; Gregor Sersa; Francesco Izzo
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

5.  Electrochemotherapy of Spinal Metastases Using Transpedicular Approach-A Numerical Feasibility Study.

Authors:  Helena Cindrič; Bor Kos; Giuseppe Tedesco; Matteo Cadossi; Alessandro Gasbarrini; Damijan Miklavčič
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.